Manusama ER - Search Results

1

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.

Nooijen PT, Manusama ER, Eggermont AM, Schalkwijk L, Stavast J, Marquet RL, de Waal RM, Ruiter DJ. Nooijen PT, et al. Among authors: manusama er. Br J Cancer. 1996 Dec;74(12):1908-15. doi: 10.1038/bjc.1996.652. Br J Cancer. 1996. PMID: 8980389 Free PMC article.

2

Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approach.

Manusama ER, Stavast J, Durante NM, Marquet RL, Eggermont AM. Manusama ER, et al. Eur J Surg Oncol. 1996 Apr;22(2):152-7. doi: 10.1016/s0748-7983(96)90671-x. Eur J Surg Oncol. 1996. PMID: 8608832

3

Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat.

Manusama ER, Nooijen PT, Stavast J, Durante NM, Marquet RL, Eggermont AM. Manusama ER, et al. Br J Surg. 1996 Apr;83(4):551-5. doi: 10.1002/bjs.1800830438. Br J Surg. 1996. PMID: 8665257

4

Regional application of TNF alpha in the treatment of cancer: a preclinical-clinical interactive program.

Eggermont AM, Manusama ER, ten Hagen TL. Eggermont AM, et al. Among authors: manusama er. J Inflamm. 1995-1996;47(1-2):104-13. J Inflamm. 1995. PMID: 8913937 Review.

5

Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program.

Manusama ER, Nooijen PT, Ten Hagen TL, Van Der Veen AH, De Vries MW, De Wilt JH, Van Ijken MG, Marquet RL, Eggermont AM. Manusama ER, et al. Semin Surg Oncol. 1998 Apr-May;14(3):232-7. doi: 10.1002/(sici)1098-2388(199804/05)14:3<232::aid-ssu7>3.0.co;2-9. Semin Surg Oncol. 1998. PMID: 9548606

6

Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats.

Manusama ER, Nooijen PT, Stavast J, de Wilt JH, Marquet RL, Eggermont AM. Manusama ER, et al. J Surg Res. 1998 Aug;78(2):169-75. doi: 10.1006/jsre.1997.5256. J Surg Res. 1998. PMID: 9733636

7

Toxicity and antitumor activity of interferon gamma alone and in combinations with TNFalpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats.

Manusama ER, De Wilt JH, Ten Hagen TL, Marquet RL, Eggermont AM. Manusama ER, et al. Oncol Rep. 1999 Jan-Feb;6(1):173-7. doi: 10.3892/or.6.1.173. Oncol Rep. 1999. PMID: 9864423

8

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats.

de Wilt JH, Manusama ER, van Tiel ST, van Ijken MG, ten Hagen TL, Eggermont AM. de Wilt JH, et al. Among authors: manusama er. Br J Cancer. 1999 Apr;80(1-2):161-6. doi: 10.1038/sj.bjc.6690335. Br J Cancer. 1999. PMID: 10389992 Free PMC article.

9

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.

Bickels J, Manusama ER, Gutman M, Eggermont AM, Kollender Y, Abu-Abid S, Van Geel AN, Lev-Shlush D, Klausner JM, Meller I. Bickels J, et al. Among authors: manusama er. Eur J Surg Oncol. 1999 Oct;25(5):509-14. doi: 10.1053/ejso.1999.0687. Eur J Surg Oncol. 1999. PMID: 10527599

10

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions.

de Wilt JH, Manusama ER, van Etten B, van Tiel ST, Jorna AS, Seynhaeve AL, ten Hagen TL, Eggermont AM. de Wilt JH, et al. Among authors: manusama er. Br J Cancer. 2000 Nov;83(9):1176-82. doi: 10.1054/bjoc.2000.1447. Br J Cancer. 2000. PMID: 11027431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters